Advanced liver disease patients given new hope with 'poo transplant'

Brasil Notícia Notícia

Advanced liver disease patients given new hope with 'poo transplant'
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 nottslive
  • ⏱ Reading Time:
  • 32 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 52%

A clinical trial to test the effectiveness of a 'poo transplant' for people with advanced liver disease is being launched

A clinical trial to test the effectiveness of a "poo transplant" for people with advanced liver disease is being launched in the UK. The Promise trial will investigate whether consuming freeze-dried stool - or "crapsules" - can improve the gut health of patients with cirrhosis, a condition where the liver is scarred and permanently damaged.

Dr Lindsey Edwards, from King's College London, which is leading the clinical trial, said: "Infections, especially resistant infections, are a death sentence to liver patients. Patients with chronic liver disease are often prescribed antibiotics, however, they are at high risk of multidrug-resistant infections.

About 300 people with liver disease will be taking part in the trial funded by the National Institute for Health and Care Research UK . They will test whether stool from healthy people, which are freeze-dried into capsules that can be ingested, reduces the likelihood of getting an infection.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

nottslive /  🏆 96. in UK

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

The iPhone 15 Pro’s chipset could be far more advanced than the Galaxy S23’sThe iPhone 15 Pro’s chipset could be far more advanced than the Galaxy S23’sThe iPhone 15 Pro might remain ahead of the competition for quite a while if this is true.
Consulte Mais informação »

Newcastle close in on AC Milan star Tonali - dubbed 'the new Pirlo' - in £60m dealNewcastle close in on AC Milan star Tonali - dubbed 'the new Pirlo' - in £60m dealNewcastle are in advanced negotiations with AC Milan over a move to sign Sandro Tonali, talkSPORT understands. The Magpies are hopeful of agreeing a deal for the Italian international. The 23-year-…
Consulte Mais informação »

Newcastle close in on £45m-rated Serie A star dubbed 'the new Pirlo'Newcastle close in on £45m-rated Serie A star dubbed 'the new Pirlo'Newcastle are in advanced negotiations with AC Milan over a move for £45m rated midfielder Sandro Tonali, talkSPORT understands. The Magpies are hopeful of agreeing a deal for the Italian internati…
Consulte Mais informação »

Fatty liver disease symptoms and lifestyle changes you can make to reduce riskFatty liver disease symptoms and lifestyle changes you can make to reduce riskOne in five adults across Scotland and the rest of the UK suffer with fatty liver disease, with the condition posing serious health risk in the later stages.
Consulte Mais informação »

Var∣Decrypt: a novel and user-friendly tool to explore and prioritize variants in whole-exome sequencing data - Epigenetics & ChromatinVar∣Decrypt: a novel and user-friendly tool to explore and prioritize variants in whole-exome sequencing data - Epigenetics & ChromatinBackground High-throughput sequencing (HTS) offers unprecedented opportunities for the discovery of causative gene variants in multiple human disorders including cancers, and has revolutionized clinical diagnostics. However, despite more than a decade of use of HTS-based assays, extracting relevant functional information from whole-exome sequencing (WES) data remains challenging, especially for non-specialists lacking in-depth bioinformatic skills. Results To address this limitation, we developed Var∣Decrypt, a web-based tool designed to greatly facilitate WES data browsing and analysis. Var∣Decrypt offers a wide range of gene and variant filtering possibilities, clustering and enrichment tools, providing an efficient way to derive patient-specific functional information and to prioritize gene variants for functional analyses. We applied Var∣Decrypt on WES datasets of 10 acute erythroid leukemia patients, a rare and aggressive form of leukemia, and recovered known disease oncogenes in addition to novel putative drivers. We additionally validated the performance of Var∣Decrypt using an independent dataset of ~ 90 multiple myeloma WES, recapitulating the identified deregulated genes and pathways, showing the general applicability and versatility of Var∣Decrypt for WES analysis. Conclusion Despite years of use of WES in human health for diagnosis and discovery of disease drivers, WES data analysis still remains a complex task requiring advanced bioinformatic skills. In that context, there is a need for user-friendly all-in-one dedicated tools for data analysis, to allow biologists and clinicians to extract relevant biological information from patient datasets. Here, we provide Var∣Decrypt (trial version accessible here: https://vardecrypt.com/app/vardecrypt ), a simple and intuitive Rshiny application created to fill this gap. Source code and detailed user tutorial are available at https://gitlab.com/mohammadsalma/vardecrypt .
Consulte Mais informação »

Warning as ‘silent’ but deadly disease on the rise - the 3 signs you must knowWarning as ‘silent’ but deadly disease on the rise - the 3 signs you must knowCASES of a deadly non-alcoholic fatty liver disease have been soaring over the past three decades, according to a new study. The condition, which causes inflammation of the organ, can lead to liver…
Consulte Mais informação »



Render Time: 2025-02-28 08:05:19